PRESCIENT THERAPEUTICS LIMITED — Share Issue/Capital Change 2025

Jul 13, 2025

Appendix 3H - Notification of cessation of securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

PRESCIENT THERAPEUTICS LIMITED

Announcement Type

New announcement

Date of this announcement

Monday July 14, 2025

Details of +securities that have ceased

		Number of
ASX +security		+securities that	The +securities have	Date of
code	Security description	have ceased	ceased due to	cessation
PTXAK	OPTION EXPIRING	1,000,000	Expiry of option or other	12/07/2025
	12-JUL-2025 EX $0.371		convertible security without
			exercise or conversion

Refer to next page for full details of the announcement

Appendix 3H - Notification of cessation of securities

1 / 4

Appendix 3H - Notification of cessation of securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Announcement Details

1.1 Name of +Entity

PRESCIENT THERAPEUTICS LIMITED

We (the entity named above) provide the following information about our issued capital.

1.2 Registered Number Type Registration Number ABN 56006569106

1.3 ASX issuer code

PTX

1.4 The announcement is

New announcement

1.5 Date of this announcement

14/7/2025

Appendix 3H - Notification of cessation of securities

2 / 4

Appendix 3H - Notification of cessation of securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Details of +equity securities or +debt securities that have ceased

ASX +Security Code and Description

PTXAK : OPTION EXPIRING 12-JUL-2025 EX $0.371

Unquoted +equity securities that have ceased

Number of securities that have ceased

1,000,000

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

Date of cessation Is the entity paying any consideration for the cessation? No 12/7/2025

Any other information the entity wishes to notify to ASX about the cessation?

Appendix 3H - Notification of cessation of securities

3 / 4

Appendix 3H - Notification of cessation of securities

==> picture [21 x 22] intentionally omitted <==

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
PTX : ORDINARY FULLY PAID	805,319,793
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
	Total number of
ASX +security code and description	+securities on issue
PTXAQ : OPTION EXPIRING 11-DEC-2028 EX $0.0621	1,415,000
PTXAK : OPTION EXPIRING 12-JUL-2025 EX $0.371	0
PTXAR : OPTION EXPIRING 20-JAN-2030 EX $0.0812	24,000,000
PTXAJ : OPTION EXPIRING 07-JUL-2026 EX $0.358	4,000,000
PTXAL : OPTION EXPIRING 04-NOV-2026 EX $0.412	1,000,000
PTXAP : OPTION EXPIRING 15-MAY-2027 EX $0.1309	1,415,000

3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Appendix 3H - Notification of cessation of securities

4 / 4